Rafferty Asset Management
JANX icon

Rafferty Asset Management’s Janux Therapeutics JANX Stock Holding History

Rafferty Asset Management’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Sell
75,732
-99,516
-57% -$1.36M ﹤0.01% 753
2025
Q4 		$2.42M Buy
175,248
+99,052
+130% +$2.33M 0.01% 608
2025
Q3 		$1.86M Buy
76,196
+29,267
+62% +$713K 0.01% 660
2025
Q2 		$1.08M Sell
46,929
-9,350
-17% -$246K ﹤0.01% 750
2025
Q1 		$1.52M Buy
56,279
+4,111
+8% +$155K 0.01% 649
2024
Q4 		$2.79M Sell
52,168
-13,522
-21% -$715K 0.01% 546
2024
Q3 		$2.98M Sell
65,690
-11,556
-15% -$503K 0.01% 538
2024
Q2 		$3.24M Buy
+77,246
New +$3.63M 0.01% 512

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return